secwatch.observer — SEC 8-K summary
======================================

Issuer:     SHOULDER INNOVATIONS, INC. (SI)
CIK:        0001699350
Form:       8-K
Filed at:   2026-03-10T23:59:59+00:00
Accession:  0001699350-26-000010
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shoulder Innovations reports Q4 revenue $14.4M (+65%), FY2025 revenue $47.3M (+50%), guides 2026 to $62-65M
--------------------------------------------------------------------------------

- Net revenue Q4 $14.4M (+65% YoY); FY2025 $47.3M (+50% YoY). Gross margin 76.7% Q4, 76.5% FY.
- Net loss Q4 $7.8M, FY $40.4M; Adjusted EBITDA loss Q4 $7.0M, FY $36.1M.
- Sold 1,976 implant systems in Q4 (+62%); ended 2025 with 134 core/contender surgeons (+61%).
- FY2026 revenue guidance $62-65M (31-37% growth); cash $124.3M at Dec 31, 2025.
- Director Michael Carusi not standing for re-election; Drew Hykes appointed to Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699350/000169935026000010/0001699350-26-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699350/000169935026000010/si-20260310.htm
  HTML page:      https://secwatch.observer/filing/0001699350-26-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer